ACA
GSK icon

Aptus Capital Advisors’s GSK GSK Stock Holding History

Aptus Capital Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-57,600
Closed -$3.38M – 450
2019
Q4 		$3.38M Buy
57,600
+10,400
+22% +$578K 0.24% 73
2019
Q3 		$2.52M Buy
+47,200
New +$2.43M 0.14% 93

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Aptus Capital Advisors's GSK Position: Q1 2026 in Review

Aptus Capital Advisors reduced its GSK (GSK) stake by 2.4% in Q1 2026, selling an estimated $9.48K and leaving 7,241 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

Aptus Capital Advisors first reported a position in GSK in Q3 2019 and has held it in 11 quarters since. The position peaked at $3.39M in Q4 2019. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Aptus Capital Advisors held 7,241 shares of GSK worth $400K as of Q1 2026.
  • Aptus Capital Advisors sold 175 GSK shares in Q1 2026, an estimated $9.48K.
  • GSK made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q1 2026, its #784 holding.
  • Aptus Capital Advisors first reported a position in GSK in Q3 2019 and has held it in 11 quarters since.
  • Aptus Capital Advisors's GSK position peaked at $3.39M in Q4 2019.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Aptus Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.